Treg cell Notch receptors drive SARS-CoV-2-induced MIS-C

In a recent study under consideration at Nature Portfolio Journal and posted to the Research Square* preprint server, researchers demonstrated the evolution of multi-system inflammatory syndrome in children (MIS-C) following acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. MIS-C is a rare hyperinflammatory immune response to acute SARS-CoV-2 infection observed in children. MIS-C patients exhibit features such as intense […]

Continue reading »

Low-dose lithium attenuates kidney aging in mice

Best known therapeutically as a treatment for bipolar disorder, lithium has long intrigued researchers with its potential age-defying properties. The element has been shown in lab experiments to extend the lifespan of fruit flies and roundworms, while observational studies have suggested tap water naturally laced with trace amounts of lithium might improve human longevity. Researchers at The University of Toledo […]

Continue reading »

Sanitizing device kills SARS-CoV-2 virus in 60 seconds

A new made-in-Alberta sanitization product aimed at stopping the spread of SARS-CoV-2 will soon be in use at the Edmonton International Airport and government offices in Calgary and Edmonton, thanks to a partnership with scientists at the University of Alberta’s Biosafety Level 3 Lab. The TESER ACT unit uses ultraviolet-C light from hundreds of LED light bulbs to kill viruses […]

Continue reading »

Aprotinin could inhibit virus replications by preventing SARS-CoV-2 entry into host cells

A clinical study from Spain recently confirmed laboratory experiments made by researchers of Goethe University Frankfurt and University of Kent who showed that the protease inhibitor aprotinin prevented cells to be infected by SARS-CoV2. The authors of the clinical study report that patients receiving an aprotinin aerosol could be discharged from hospital significantly earlier. SARS-CoV-2, the coronavirus that causes COVID-19, […]

Continue reading »

Long-Term Smell Loss in COVID-19 Tied to Brain Damage

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Patients with COVID-19, especially those with an altered sense of smell, have significantly more axon and microvasculopathy damage in the brain’s olfactory tissue versus non-COVID patients. These new findings from a post-mortem study may explain long-term loss of smell in some patients with the virus. “The […]

Continue reading »
1 485 486 487 488 489 1,322